Reports related to this article:
Project(s): View 3 related projects in PECWeb
Plant(s): View 3 related plants in PECWeb
Released March 25, 2020 | Cordoba
en
South America's Pharmaceutical & Biotech Industry has begun to feel the impact of COVID-19, and most companies are postponing maintenance and capital projects, and only focusing on operating plants with essential staff.
For instance, Brazilian company Geolab stopped construction on a project in Anapolis, Goias, where the project's completion may take at least four more months. The same situation is happening with a grassroot project in Chorrillos, Peru, where Laboratorios Induquimica has re-scheduled authorization for expenditure within six months. In Argentina, Sinergium Biotech may not review the authorization for expenditure for its line addition project in Garin, Buenos Aires, until July.
For instance, Brazilian company Geolab stopped construction on a project in Anapolis, Goias, where the project's completion may take at least four more months. The same situation is happening with a grassroot project in Chorrillos, Peru, where Laboratorios Induquimica has re-scheduled authorization for expenditure within six months. In Argentina, Sinergium Biotech may not review the authorization for expenditure for its line addition project in Garin, Buenos Aires, until July.
